These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 34295189)
1. Identification of a Prognostic Index Based on a Metabolic-Genomic Landscape Analysis of Hepatocellular Carcinoma (HCC). Yang X; Liu Q; Zou J; Li YK; Xie X Cancer Manag Res; 2021; 13():5683-5698. PubMed ID: 34295189 [TBL] [Abstract][Full Text] [Related]
2. Identification and validation of a prognostic index based on a metabolic-genomic landscape analysis of ovarian cancer. Zhang QF; Li YK; Chen CY; Zhang XD; Cao L; Quan FF; Zeng X; Wang J; Liu J Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32880385 [TBL] [Abstract][Full Text] [Related]
3. A Novel Metabolism-Related Signature as a Candidate Prognostic Biomarker for Hepatocellular Carcinoma. Wang Z; Embaye KS; Yang Q; Qin L; Zhang C; Liu L; Zhan X; Zhang F; Wang X; Qin S J Hepatocell Carcinoma; 2021; 8():119-132. PubMed ID: 33758763 [TBL] [Abstract][Full Text] [Related]
4. Identification of a metabolism-related gene expression prognostic model in endometrial carcinoma patients. Jiang P; Sun W; Shen N; Huang X; Fu S BMC Cancer; 2020 Sep; 20(1):864. PubMed ID: 32894095 [TBL] [Abstract][Full Text] [Related]
5. Prognostic Role and Potential Mechanisms of the Ferroptosis-Related Metabolic Gene Signature in Hepatocellular Carcinoma. Dai T; Li J; Lu X; Ye L; Yu H; Zhang L; Deng M; Zhu S; Liu W; Wang G; Yang Y Pharmgenomics Pers Med; 2021; 14():927-945. PubMed ID: 34377010 [TBL] [Abstract][Full Text] [Related]
6. [Differential analysis of gene expression profiles in hepatocellular carcinoma patients with high and low levels of alpha-fetoprotein]. Wang XJ; Shen RF; Wang X; Wang YR; Xiao T Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):396-402. PubMed ID: 32482029 [No Abstract] [Full Text] [Related]
7. Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma. Liu GM; Zeng HD; Zhang CY; Xu JW Cancer Cell Int; 2019; 19():138. PubMed ID: 31139015 [TBL] [Abstract][Full Text] [Related]
8. Five metastasis-related mRNAs signature predicting the survival of patients with liver hepatocellular carcinoma. Chen C; Liu YQ; Qiu SX; Li Y; Yu NJ; Liu K; Zhong LM BMC Cancer; 2021 Jun; 21(1):693. PubMed ID: 34116652 [TBL] [Abstract][Full Text] [Related]
9. Identification and Validation of an 6-Metabolism-Related Gene Signature and Its Correlation With Immune Checkpoint in Hepatocellular Carcinoma. Ren H; Li W; Liu X; Li S; Guo H; Wang W; Zhao N Front Oncol; 2021; 11():783934. PubMed ID: 34869039 [TBL] [Abstract][Full Text] [Related]
10. Identification of a five-gene signature in association with overall survival for hepatocellular carcinoma. Yang L; Yin W; Liu X; Li F; Ma L; Wang D; Li H PeerJ; 2021; 9():e11273. PubMed ID: 33986994 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis reveals a metabolic ten-gene signature in hepatocellular carcinoma. Zhu Z; Li L; Xu J; Ye W; Chen B; Zeng J; Huang Z PeerJ; 2020; 8():e9201. PubMed ID: 32518728 [TBL] [Abstract][Full Text] [Related]
12. Development and validation of an RNA binding protein-associated prognostic model for hepatocellular carcinoma. Wang M; Huang S; Chen Z; Han Z; Li K; Chen C; Wu G; Zhao Y BMC Cancer; 2020 Nov; 20(1):1136. PubMed ID: 33228611 [TBL] [Abstract][Full Text] [Related]
13. Identification of 40S ribosomal protein S8 as a novel biomarker for alcohol‑associated hepatocellular carcinoma using weighted gene co‑expression network analysis. Bi N; Sun Y; Lei S; Zeng Z; Zhang Y; Sun C; Yu C Oncol Rep; 2020 Aug; 44(2):611-627. PubMed ID: 32627011 [TBL] [Abstract][Full Text] [Related]
14. Identification and Validation of Ubiquitin-Specific Proteases as a Novel Prognostic Signature for Hepatocellular Carcinoma. Ni W; Bian S; Zhu M; Song Q; Zhang J; Xiao M; Zheng W Front Oncol; 2021; 11():629327. PubMed ID: 33718205 [TBL] [Abstract][Full Text] [Related]
15. Identification of Energy Metabolism Genes for the Prediction of Survival in Hepatocellular Carcinoma. Chen Q; Li F; Gao Y; Xu G; Liang L; Xu J Front Oncol; 2020; 10():1210. PubMed ID: 32903581 [TBL] [Abstract][Full Text] [Related]
16. Development of a novel lipid metabolism-based risk score model in hepatocellular carcinoma patients. Wang W; Zhang C; Yu Q; Zheng X; Yin C; Yan X; Liu G; Song Z BMC Gastroenterol; 2021 Feb; 21(1):68. PubMed ID: 33579192 [TBL] [Abstract][Full Text] [Related]
17. Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma. Zhu ZY; Tang N; Wang MF; Zhou JC; Wang JL; Ren HZ; Shi XL Front Immunol; 2021; 12():781087. PubMed ID: 35069553 [TBL] [Abstract][Full Text] [Related]
18. Identification of the Tumor Immune Microenvironment and Therapeutic Biomarkers by a Novel Molecular Subtype Based on Aging-Related Genes in Hepatocellular Carcinoma. Cai D; Zhao Z; Hu J; Dai X; Zhong G; Gong J; Qi F Front Surg; 2022; 9():836080. PubMed ID: 35392063 [TBL] [Abstract][Full Text] [Related]
19. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach. Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824 [TBL] [Abstract][Full Text] [Related]
20. Identification, Verification and Pathway Enrichment Analysis of Prognosis-Related Immune Genes in Patients With Hepatocellular Carcinoma. Zhu Z; Song M; Li W; Li M; Chen S; Chen B Front Oncol; 2021; 11():695001. PubMed ID: 34616672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]